Skip to main content
. 2017 Dec 4;8(67):111770–111779. doi: 10.18632/oncotarget.22907

Table 1. The prevalence rate of DM and IFG in patients with TSCC.

Prevalence rate SPRs* SPRs in the Chinese population#
DM IFG DM IFG DM IFG
Total 13.97% 20.76% 12.84% 18.88% 9.7% 15.5%
Male (%) 11.19% 17.13% 11.98% 18.34% 10.6% 16.1%
Female (%) 17.69% 25.58% 13.67% 19.40% 8.8% 14.9%

*SPRs: standardized prevalence rates. #: Data from Ref [2].